89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study

Clinical trial NCT06750419 · RECRUITING

Trial details

NCT number: NCT06750419
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma

Start date: 2024-11-06
Primary completion: 2026-06-30
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.